Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Insulet
PODD
$9.99B
| $44.3M | 0.06% |
150,400
+138,900
| +1,208% | +$38.3M |
|
377
Shutterstock
SSTK
$202M
| $44.1M | 0.06% |
836,601
-70,200
| -8% | -$3.58M |
|
|
TXNM
378
TXNM Energy Inc
TXNM
$5.91B
| $44M | 0.06% |
902,000
+42,544
| +5% | +$2.03M |
|
379
Caesars Entertainment
CZR
$6.04B
| $44M | 0.06% |
1,057,597
+504,400
| +91% | +$22.5M |
|
380
Avantor
AVTR
$9.29B
| $43.9M | 0.06% |
2,083,600
-2,870,700
| -58% | -$59.4M |
|
|
SEE
381
DELISTED
Sealed Air
SEE
| $43.8M | 0.06% |
878,821
-43,100
| -5% | -$2.1M |
|
382
JetBlue
JBLU
$2.21B
| $43.8M | 0.06% |
6,759,416
+827,433
| +14% | +$6.05M |
|
383
Brookfield Renewable
BEPC
$6.43B
| $43.8M | 0.06% |
1,589,441
-130,200
| -8% | -$4.02M |
|
384
IAMGOLD
IAG
$10.4B
| $43.8M | 0.06% |
16,961,100
-697,496
| -4% | -$1.21M |
|
385
Medpace
MEDP
$16.8B
| $43.3M | 0.06% |
203,988
-62,200
| -23% | -$12.4M |
|
|
MODV
386
DELISTED
ModivCare
MODV
| $43.2M | 0.06% |
480,901
-59,398
| -11% | -$5.3M |
|
387
Veeva Systems
VEEV
$38.5B
| $43.1M | 0.06% |
267,100
-245,500
| -48% | -$41.9M |
|
388
Evergy
EVRG
$19.1B
| $43M | 0.06% |
+683,966
| New | +$41.1M |
|
389
Bio-Rad Laboratories Class A
BIO
$9.57B
| $43M | 0.06% |
102,143
+39,443
| +63% | +$15.9M |
|
390
Coupang
CPNG
$29.8B
| $42.9M | 0.06% |
+2,919,493
| New | +$51.5M |
|
391
Mercury Insurance
MCY
$5.9B
| $42.7M | 0.06% |
1,248,400
-36,500
| -3% | -$1.21M |
|
392
National Bank Holdings
NBHC
$1.93B
| $42.5M | 0.06% |
1,009,100
-93,600
| -8% | -$4.04M |
|
393
Honda
HMC
$40.6B
| $42.4M | 0.06% |
1,855,998
+403,500
| +28% | +$9.35M |
|
394
Boeing
BA
$182B
| $42.2M | 0.06% |
+221,300
| New | +$36.2M |
|
395
Twilio
TWLO
$37.9B
| $42M | 0.06% |
858,295
+693,595
| +421% | +$39.5M |
|
396
Teva Pharmaceuticals
TEVA
$42.7B
| $41.9M | 0.06% |
4,590,563
+250,563
| +6% | +$2.19M |
|
|
GRMN
397
Garmin
GRMN
$59.9B
| $41.7M | 0.06% |
451,842
-29,700
| -6% | -$2.62M |
|
398
Cardinal Health
CAH
$55.1B
| $41.7M | 0.06% |
+542,400
| New | +$41.2M |
|
399
Ericsson
ERIC
$33.5B
| $41.6M | 0.06% |
7,125,300
+3,647,000
| +105% | +$21.9M |
|
400
Flex
FLEX
$47.5B
| $41.6M | 0.06% |
2,571,930
+1,991,959
| +343% | +$29.9M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.